Alejandro Lillo

Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes

Gemma Navarro, Irene Reyes‐Resina, Rafael Rivas‐Santisteban et al. · Biochemical Pharmacology · 2018 · 95 citations

Medicine, Neuroscience, Pharmacology +11

Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors

Gemma Navarro, Katia Varani, Alejandro Lillo et al. · Pharmacological Research · 2020 · 93 citations · Full text

Medicine, Neuroscience, Pharmacology +12

Potentiation of cannabinoid signaling in microglia by adenosine A_2A receptor antagonists

Rafael Franco, Irene Reyes‐Resina, David Aguinaga et al. · Glia · 2019 · 56 citations

Medicine, Neuroscience, Pharmacology +17

Adenosine A2A Receptor Antagonists Affects NMDA Glutamate Receptor Function. Potential to Address Neurodegeneration in Alzheimer’s Disease

Rafael Franco, Rafael Rivas‐Santisteban, M Casanovas et al. · Cells · 2020 · 50 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors

Iu Raïch, Rafael Rivas‐Santisteban, Alejandro Lillo et al. · Pharmacological Research · 2021 · 31 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16